1. Home
  2. APGE vs CTRI Comparison

APGE vs CTRI Comparison

Compare APGE & CTRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • CTRI
  • Stock Information
  • Founded
  • APGE 2022
  • CTRI 1909
  • Country
  • APGE United States
  • CTRI United States
  • Employees
  • APGE N/A
  • CTRI N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • CTRI
  • Sector
  • APGE Health Care
  • CTRI
  • Exchange
  • APGE Nasdaq
  • CTRI Nasdaq
  • Market Cap
  • APGE 1.8B
  • CTRI 1.8B
  • IPO Year
  • APGE 2023
  • CTRI 2024
  • Fundamental
  • Price
  • APGE $39.72
  • CTRI $16.58
  • Analyst Decision
  • APGE Strong Buy
  • CTRI Hold
  • Analyst Count
  • APGE 4
  • CTRI 7
  • Target Price
  • APGE $91.33
  • CTRI $19.00
  • AVG Volume (30 Days)
  • APGE 789.9K
  • CTRI 399.3K
  • Earning Date
  • APGE 03-03-2025
  • CTRI 05-07-2025
  • Dividend Yield
  • APGE N/A
  • CTRI N/A
  • EPS Growth
  • APGE N/A
  • CTRI N/A
  • EPS
  • APGE N/A
  • CTRI N/A
  • Revenue
  • APGE N/A
  • CTRI $2,637,229,000.00
  • Revenue This Year
  • APGE N/A
  • CTRI $5.19
  • Revenue Next Year
  • APGE $795.25
  • CTRI $5.80
  • P/E Ratio
  • APGE N/A
  • CTRI N/A
  • Revenue Growth
  • APGE N/A
  • CTRI N/A
  • 52 Week Low
  • APGE $29.10
  • CTRI $14.47
  • 52 Week High
  • APGE $68.21
  • CTRI $28.65
  • Technical
  • Relative Strength Index (RSI)
  • APGE 55.27
  • CTRI N/A
  • Support Level
  • APGE $38.18
  • CTRI N/A
  • Resistance Level
  • APGE $41.07
  • CTRI N/A
  • Average True Range (ATR)
  • APGE 2.31
  • CTRI 0.00
  • MACD
  • APGE 0.22
  • CTRI 0.00
  • Stochastic Oscillator
  • APGE 63.77
  • CTRI 0.00

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.

About CTRI Centuri Holdings Inc. Common Stock

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings primarily consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. They operate under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.

Share on Social Networks: